Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: Results of a randomized, controlled comparison

To determine if newer influenza vaccines can safely improve seroprotection rates of older adults, we compared three licensed trivalent inactivated vaccines (TIVs) in a randomized, controlled trial with evaluator blinding. Participants were non-frail adults ≥ 65 y old, annually TIV-immunized. Study v...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Scheifele, David W., McNeil, Shelly A., Ward, Brian J., Dionne, Marc, Cooper, Curtis, Coleman, Brenda, Loeb, Mark, Rubinstein, Ethan, McElhaney, Janet, Hatchette, Todd, Li, Yan, Montomoli, Emanuele, Schneeberg, Amy, Bettinger, Julie A., Halperin, Scott A., Research Network, PHAC/CIHR Influenza
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2013
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981857/
https://ncbi.nlm.nih.gov/pubmed/23839537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.25580
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak